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ABSTRACT 
The aim of present research is to design and develop nanoemulsion of Econazole nitrate as effective treatment for tinea versicolor fungal 
disease. Econazole nitrate is an imidazole antifungal agent with broad spectrum activity. It belongs to BCS class II i.e. low soluble and highly 
permeable drug. Due to its poor solubility, it is incompletely absorbed after oral dosing and bioavailability varies among individuals. The drug 
efficacy of topical formulation can be limited by instability due to its poor solubility in the vehicle and low permeability. Therefore, to overcome 
these problems nanoemulsions have been designed. Topical nanoemulsion containing 1 % Econazole nitrate with different oils (oleic acid), 
surfactant (tween 20), co-surfactant (PEG 200, PEG 400) and distilled water. Various oil-in-water nanoemulsions are prepared by the 
spontaneous emulsification method. The nanoemulsion formulations that passed thermodynamic stability tests were characterized  for 
appearance, pH, FTIR, viscosity, drug content, % drug entrapment efficiency and in-vitro drug release study of Econazole nitrate determined by 
Franz diffusion cell and stability study. 
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INTRODUCTION: 
Nanoemulsion are defined as isotropic, thermodynamically 
stable transparent or translucent systems of oil and water 
which stabilize by surfactant with a droplet size usually in 
the range of 5 to 200 nm. Nanoemulsion having various 
advantages over the macroemulsion are as follows i.e., 
Nanoemulsions have a much higher surface area and free 
energy than macroemulsions that make them an effective 
transport system. This system does not show the problems 
of inherent creaming, flocculation, coalescence and 
sedimentation, which are commonly associated with 
macroemulsions. Nanoemulsions can be developed by 
spontaneous emulsification method to enhance the solubility 
and bioavailability of poorly water soluble drugs. These are 
non-toxic non-irritant hence can be easily applied to skin 
and mucous membranes. The use of nanoemulsion as 
delivery systems can improve the efficacy of a drug, allowing 
the total dose to be reduced and thus minimizing side 
effects. 
Nanoemulsion used as drug carrier in topical treatment of 
diseases especially in skin disease. They are able to 
incorporate a variety of hydrophobic and hydrophilic drugs 
to improve the accumulation of drug at the site of action and 
to decrease side effects. Nanoemulsion can provide 
sustained and controlled release of entrapped drug. 
 
Figure 1: Nanoemulsion 
In this formulation antifungal drug Econazole nitrate used to 
formulate nanoemulsion. Various conventional topical doses 
forms of Econazole nitrate are available such as cream and 
lotion however side effects are associated with Econazole 
nitrate therapy such as irritation, pain and redness; to 
overcome these problems Econazole nitrate nanoemulsion is 
prepared. Econazole nitrate belongs to BCS class II i.e. poorly 
soluble and highly permeable drug. Due to poor solubility, it 
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is incompletely absorbed after oral dosing and 
bioavailability varies among individuals. Econazole nitrate 
drug is imidazole ring containing broad-spectrum antifungal 
agent, which interacts with 14-demethylase, a cytochrome P-
450 enzyme necessary to convert lanosterol to ergosterol. 
Econazole inhibits the synthesis of ergosterol which is an 
essential component of the fungal cell membrane; this will 
increase the cellular permeability causing leakage of cellular 
contents, resulting in fungal cell death. This drug achieves 
excellent skin levels with minimal dosing. It is effective 
topically for the managing of cutaneous candidiasis and 
tinea infections of the skin. Tinea infection is characterized 
by changes in skin pigment due to colonization of the 
stratum corneum by a lipophilic fungus of the normal flora 
of the skin, known as Malassezia furfur. M. furfur is 
eradicated by the presence of Econazole nitrate in the outer 
skin layers. These preparations are applied on to the skin 
surface for providing local or systemic effect.1, 2 
Objectives: 
• The main objective of the study is to develop topical 
nanoemulsion.  
• To choose the appropriate excipients based on 
physicochemical properties of the drug. 
• To formulate and evaluate the nanoemulsion. 
• To increase the solubility of drug by nanonization. 
• To increase therapeutic effect at targeted site. 
• To reduce dose frequency and side effects.  
MATERIALS AND METHODS: 
Econazole nitrate is received as gift sample from Aarti 
pharmaceutical Pvt. Ltd. Mumbai, oleic acid, PEG 200, Tween 
20 are purchased from S.D. Lobachem, Mumbai, India, All 
chemicals and solvents are of analytical grade. 
Methods3, 4 
Determination of melting point 
Melting point of drug is determined by using capillary 
method. Drug is filled into capillary tube upto the height of 3 
mm by sealing its one end. The capillary is introduced into 
the digital melting point apparatus and the point at which 
the drug starts melting note that point until the entire 
sample get melted.  
Solubility study: 
For the purpose of solubility, beyond saturation additional 
amount of drug is added in the solvent (either aqueous or 
non-aqueous) at room temperature and kept for 24 hrs with 
rare shaking. The supernatant was taken and evaluated by 
using Shimadzu UV 1800 double beam spectrophotometer. 
Identification of drug by FTIR 
The pure drug is mixed with IR grade solvent in a proper 
ratio and applying pressure on IR plate. The sample of drug 
is then scan over the range of 4000-400 cm-1 in Perkin Elmer 
FTIR spectrometer. FTIR spectrum of Econazole nitrate 
shows the presence of the peaks which complies with the 
reference spectra. 
Identification of drug by UV- spectroscopy 
100 mg of drug (Econazole nitrate) is accurately weighed on 
digital balance and is taken into 100 ml volumetric flask. 
Sufficient quantity of methanol is added to dissolve the drug. 
The volume is made up to 100 ml using methanol to prepare 
stock solution of 100 μg/ml. 
Preparation of standard calibration curve of Econazole 
nitrate in methanol  
From the stock solution 0.2, 0.4, 0.6, 0.8, 1.0, and 1.2 ml of 
solution is pipette out into 10 ml volumetric flasks and 
volume is made up to 10 ml to form concentrations of 2, 4, 6, 
8, 10, 12 μg/ml with methanol. The absorbance was 
measured with the help of UV spectrophotometer at 271 nm 
by taking methanol as reference solution. All study done in 
triplicate (n=3) with the same instrument. 
Compatibility study 
The compatibility studies are done on Perkin Elmer FTIR 
spectrophotometer. Compatibility studies are used for 
detection of any possible chemical interaction between the 
drug and excipients used i.e., oil, surfactant and co-
surfactant. A physical mixture of drug, oil, surfactant and co-
surfactant are prepared and mix with suitable quantity of 
potassium bromide. About 100 mg of this mixture are 
compressed to form a transparent pellet using a hydraulic 
press at 15 tons pressure. This is then subjected to IR 
radiations ranges from 4000 to 400 cm-1 in a Perkin Elmer 
FTIR spectrophotometer. The IR spectrum of the physical 
mixture is compare with those of pure drug, oil, surfactant 
and cosurfactant and matching is done to detect any 
appearance or disappearance of peaks.5 
Pseudo-ternary phase diagram study  
Constructing pseudo-ternary phase diagrams is time 
consuming, particularly when the aim is to accurately define 
the phase boundary. Care is taken to ensure that 
observations are not made on metastable systems, although 
the free energy required to form an emulsion is very low, the 
formation is thermodynamically spontaneous. The 
relationship between the phase behavior of a mixture and its 
composition can be captured with the aid of a phase 
diagram. Oleic acid (as oil), Tween 20 (surfactant), and PEG 
200 (co-surfactant) are selected to study the phase diagrams 
in detail. Pseudo ternary phase diagrams are constructed 
separately for each surfactants mixture ratio to identify the 
o/w nanoemulsion regions. The pseudo-ternary phase 
diagram was developed by using the aqueous titration 
method. Surfactant (Tween 20) and co-surfactant (PEG 200) 
are mixed (surfactants mixture) in different volume ratios 
(1:1, 1:2, 2:1). These surfactants mixture ratios are chosen to 
reflect the increasing concentration of the co-surfactant with 
respect to surfactant for the detailed study of the phase 
diagrams in the nanoemulsion formulation. Oleic acid 
optimize as an oil phase based on the solubility study. For 
each phase diagram, oil (oleic acid) and specific surfactants 
mixture ratios were mixed thoroughly in different volume 
ratios from 1:9 to 9:1. Thirteen different combinations of oil 
and surfactants mixture (1:1, 1:2) are made for the study to 
define the boundaries of the phases precisely formed in the 
phase diagrams.  Aqueous phase is slowly titrated for each 
combination of oil and surfactants mixture separately. 5 ml 
of aqueous phase is added at each interval upto 50ml under 
magnetic stirring and visually observed for phase clarity and 
flow ability. Calculations for the ratios of oil and surfactants 
mixture are also done simultaneously. The physical state is 
plotted on a pseudo-three-component phase diagram with 
one axis representing the aqueous phase, the second 
representing the oil phase, and third representing a mixture 
of surfactant and co-surfactant (surfactants mixture) at a 
fixed volume ratio. 5, 6
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Preparation method of Nanoemulsion: 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Spontaneous emulsification method 
Table 1: Formulation of nanoemulsion 
Sr. 
No. 
Formulation 
surfactants 
mixture (ratio) 
Oil/surfactants 
mixture (ratio) 
%w/w of components in 
Nanoemulsion formulation 
Drug 
% 
w/w 
Oil S.mix Water 
1 F1 1:1 1:9 5.00 45.00 50 1 
2 F2 1:1 1:8 5.00 40.00 55 1 
3 F3 1:1 1:7 5.00 35.00 60 1 
4 F4 1:2 1:9 5.00 45.00 50 1 
5 F5 1:2 1:8 5.00 40.00 55 1 
6 F6 1:2 1:7 5.00 35.00 60 1 
 
EVALUATION OF NANOEMULSION7,8: 
Thermodynamic stability 
The selected formulation is subjected to different 
thermodynamic stability tests.  
Heating cooling cycle 
The temperature of refrigerators between 4° and 45° of six 
cycles with storage at each temperature of not less than 48 
hr is studied. Those formulations, which are stable at these 
temperatures, are subjected to centrifugation.  
Centrifugation 
The prepared formulations that are passed for 
centrifugation are centrifuged at 5000 rpm for 30 min by 
using centrifuge. The formulations that did not show any 
phase separated were taken to further tests.  
Measurement of pH: pH of various nanoemulsions 
formulations are determining by using digital pH meter. 1 
gm of nanoemulsion is dissolved in 100 ml of distilled water 
and pH was measured.  The measurement of formulation is 
done in triplicate to avoid error. 
Percentage drug content: 1 ml of nanoemulsion is mixed 
with 10 ml of suitable solvent. Aliquots of different 
concentration are prepared and by using suitable dilutions 
after filtering the stock solution; absorbance is measured by 
UV spectroscopy. Drug content is calculated by using the 
equation obtains from linear regression analysis of 
calibration curve. 
Determination of % transparency and drug 
precipitation   
Formulations of different ratio are selected on the basis of 
ternary phase diagram. Transparency study is made to find 
out the maximum % transparency and drug precipitation 
between oil, surfactants mixture (surfactant and co-
surfactant) and water containing 1% drug. (Nanoemulsion 
system is a clear transparent system when diluted with 
distilled water). 
Viscosity determination 
Viscosity of nanoemulsion is determined by using Brookfield 
viscometer. 20 ml of nanoemulsion is filled in a 25 ml beaker 
and the viscosity is measured using spindle number 6 at 10 
rpm. 
In vitro Diffusion studies: 
The diffusion studies of the prepared nanoemulsions are 
performed by using Franz diffusion cell with the aid of 
cellophane membrane. Nanoemulsion sample (5ml) is taken 
in cellophane membrane and the diffusion studies are 
Prepare homogeneous mixture of oil, surfactant and econazole nitrate drug. 
Drug was accurately weighted to represent 1%w/w of the total weight of the 
nanoemulsion formulation and then added to the previous mixture. 
Oil phase then added drop wise to the aqueous phase with continuous mixing 
using magnetic stirring for 30 min, O/W nanoemulsion is formed. 
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carried out at 37 ± 1 °C using 250 ml of (25%) methanolic 
phosphate buffer (pH 7.4) as the dissolution medium. 5 ml of 
each sample was withdrawn periodically at 1, 2, 3, 4, 5, 6, 7 
and 8 hrs and each sample is replaced with equal volume of 
fresh dissolution medium in order to maintain sink 
condition. Samples are analyzed by UV- spectrophotometer 
at 271 nm for drug content. 
RESULT AND DISCUSSION: 
The present study was attempted to prepare nanoemulsion 
of Econazolenitrate for effective treatment of fungal disease. 
Total six nanoemulsion formulations are prepared and 
evaluated for various parameters: 
Organoleptic properties  
Organoleptic properties of Econazole nitrate are found to be 
as per USP NF monograph. 
Table 2: Organoleptic properties 
Sr. No. Test Specification Observation 
1.  Colour White White 
2.  Odour Odorless Odorless 
3.  Nature Amorphous Amorphous 
  
Spreadability: The Spreadability is good and sticks well on 
skin. 
Melting point analysis 
The melting point of Econazole nitrate was observed to be 
160 0C which complies with melting range of standard 161-
165 0C. 
Solubility: Solubility of Econazole nitrate was found to be in 
different solvents are given below-
 
Table 3: Solubility study 
Sr. No. Solvent system 
Specification as per 
USP 
Result 
1 Ethanol Freely soluble Freely soluble 
2 Oleic acid Soluble Soluble 
3 Tween 20 Soluble Soluble 
4 PEG 200 Soluble Soluble 
5 Methanol Freely Soluble Freely Soluble 
6 Water Slightly soluble Slightly soluble 
7 chloroform Insoluble Insoluble 
8 Ether Insoluble Insoluble 
  
Identification of drug through UV spectroscopy 
Standard calibration curve of Econazole nitrate as pure drug in methanol 
Table 4: Standard calibration curve of Econazole nitrate 
Concentration 
(µg/ml) 
Absorbance 
2 0.204 
4 0.440 
6 0.675 
8 0.898 
10 1.110 
12 1.310 
  
UV shows that Econazole nitrate gives maximum absorption at 271 nm and figured in linear standard calibration curve shown 
in fig no 3. 
 
Figure 3: Standard calibration curve of Econazolenitrate in methanol 
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Determination of drug-excipients compatibility study 
 
Figure 4: FTIR of Econazolenitrate 
 
Figure 5: FTIR of Nanoemulsion formulation 
From FTIR it can be said that there was no incompatibility between drug and excipient as shown in fig. no. 4 & 5.  
Thermodynamic stability 
Table 5: Thermodynamic stability study 
Formulation code Heating Cooling Cycle Centrifugation 
F1 Stable No phase separation 
F2 Stable No phase separation 
F3 Stable No phase separation 
F4 Stable No phase separation 
F5 Stable No phase separation 
F6 Stable No phase separation 
 
pH, Viscosity and % Drug content: 
Table 6: Characterization of Nanoemulsion 
Formula code pH Viscosity (cp) Drug content (%) 
F1 5.5 5229 95.92 
F2 5.8 4332 96.32 
F3 5.2 4320 95.45 
F4 5.3 4850 94.66 
F5 6.5 5920 98.78 
F6 5.2 4530 94.65 
 
pH of prepared nanoemulsion formulations was found in the range of 5.5-6.5 and tabulated in table 6. 
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The percentage drug content of prepared nanoemulsion formulation was found to be 94 to 98 % and tabulated in table 6. 
The mean average viscosity was found to be 4000 to 6000 cp, F5 batch shows highest viscosity and tabulated in table 6. 
 
Figure 6: Viscosity of nanoemulsion formulation 
In-vitro drug release: 
Table 7: In-vitro drug release (in %) 
Time in 
hrs 
F1 F2 F3 F4 F5 F6 
0.5 6.86 5.95 4.5 3.68 8.22 5.79 
1 12.77 11.86 10.95 9.59 14.13 7.97 
1.5 22.75 15.95 17.29 20.45 25.49 16.09 
2 35.04 33.22 30.04 28.68 38.22 27.16 
2.5 46.4 44.13 43.22 40.04 52.76 40.36 
3 57.31 55.04 53.22 51.58 59.58 50.6 
3.5 68.3 65.53 60.12 67.20 69.10 64.23 
4 71.2 70.2 71.5 71.21 75.25 71.15 
4.5 76.2 75.25 76.35 76.35 85.25 76.45 
5 81.45 81.78 81.23 82.10 90.24 81.65 
5.5 90.23 90.52 90.23 90.78 94.70 90 
6 93.25 92.23 90.7 96.12 98.12 95.25 
 
 
Figure 7: % In vitro drug release 
Result of in-vitro drug release from different formulations 
are tabulated in table 7 and graphically shown in fig.no.7. 
The prepared formulation batch F5 shows the better release 
profile as compared to other preparation F1, F2, F3, F4 and 
F6. 
CONCLUSION: 
The present work concluded that Econazole Nitrate 
containing nanoemulsion formulation for solubility 
enhancement was successfully prepared by the spontaneous 
emulsification method. Nanoemulsion is more acceptable for 
the topical drug administration. Oleic acid, span 80 
(surfactant) and ethanol (co-surfactant) was successfully 
used as a suitable carrier system for incorporating econazole 
for topical drug delivery. Various formulations were 
prepared as per the composition and drug loaded in 
nanoemulsion. The prepared formulation of F5 shows the 
better release profile than others. From above result 
concluded that nanoemulsion drug delivery system can be 
effective for topical application in the treatment of fungal 
diseases and further study on an animal being need to 
perform before its commercial use. 
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